19-50210557-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001145809.2(MYH14):​c.192G>T​(p.Gly64Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00411 in 1,582,576 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G64G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 15 hom. )

Consequence

MYH14
NM_001145809.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.569

Publications

2 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 19-50210557-G-T is Benign according to our data. Variant chr19-50210557-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 44052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.569 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00278 (424/152362) while in subpopulation NFE AF = 0.00513 (349/68032). AF 95% confidence interval is 0.00469. There are 0 homozygotes in GnomAd4. There are 187 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 424 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145809.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH14
NM_001145809.2
MANE Select
c.192G>Tp.Gly64Gly
synonymous
Exon 2 of 43NP_001139281.1Q7Z406-2
MYH14
NM_001077186.2
c.192G>Tp.Gly64Gly
synonymous
Exon 2 of 42NP_001070654.1Q7Z406-6
MYH14
NM_024729.4
c.192G>Tp.Gly64Gly
synonymous
Exon 2 of 41NP_079005.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH14
ENST00000642316.2
MANE Select
c.192G>Tp.Gly64Gly
synonymous
Exon 2 of 43ENSP00000493594.1Q7Z406-2
MYH14
ENST00000599920.5
TSL:1
c.192G>Tp.Gly64Gly
synonymous
Exon 2 of 24ENSP00000469573.1M0QY43
MYH14
ENST00000425460.6
TSL:5
c.192G>Tp.Gly64Gly
synonymous
Exon 2 of 42ENSP00000407879.1Q7Z406-6

Frequencies

GnomAD3 genomes
AF:
0.00278
AC:
424
AN:
152248
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000771
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00513
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00229
AC:
432
AN:
188774
AF XY:
0.00232
show subpopulations
Gnomad AFR exome
AF:
0.00101
Gnomad AMR exome
AF:
0.000418
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00282
Gnomad NFE exome
AF:
0.00453
Gnomad OTH exome
AF:
0.000598
GnomAD4 exome
AF:
0.00425
AC:
6077
AN:
1430214
Hom.:
15
Cov.:
33
AF XY:
0.00409
AC XY:
2896
AN XY:
708854
show subpopulations
African (AFR)
AF:
0.000794
AC:
26
AN:
32740
American (AMR)
AF:
0.000502
AC:
20
AN:
39830
Ashkenazi Jewish (ASJ)
AF:
0.0000390
AC:
1
AN:
25644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37914
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82310
European-Finnish (FIN)
AF:
0.00405
AC:
200
AN:
49364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5732
European-Non Finnish (NFE)
AF:
0.00519
AC:
5693
AN:
1097464
Other (OTH)
AF:
0.00231
AC:
137
AN:
59216
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
376
752
1127
1503
1879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00278
AC:
424
AN:
152362
Hom.:
0
Cov.:
32
AF XY:
0.00251
AC XY:
187
AN XY:
74518
show subpopulations
African (AFR)
AF:
0.000769
AC:
32
AN:
41598
American (AMR)
AF:
0.000980
AC:
15
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00513
AC:
349
AN:
68032
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00245
Hom.:
0
Bravo
AF:
0.00243

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
5
not specified (5)
-
-
1
Autosomal dominant nonsyndromic hearing loss 4A (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
7.8
DANN
Benign
0.77
PhyloP100
-0.57
PromoterAI
0.11
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181055215; hg19: chr19-50713814; API